[1] |
XU Xiuhe, HE Xiaoli, ZHOU Jiashun, PAN Lizhu, ZHOU Zhuojun, LI Jiayue, WANG Caixia, YUAN Wei, ZHU Guiqi.
Effects of scacia honey on serum uric acid level and renal injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 743-750.
|
[2] |
LI Yuanfang, CUI Zhaoqiang.
Treatment of hypertension complicated with hyperuricemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 428-432.
|
[3] |
CHEN Yu, GU Bing, LI Huanan.
Modulating gut miocrobiota: a new strategy in the treatment of gout
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1307-1314.
|
[4] |
CHEN Aiying, CHENG Min, MIAO Yunping, YE Xiaodi, TIAN Xuejun, ZHENG Gaoli.
Pharmacokinetics and tissue distribution characteristics of sunitinib#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1105-1110.
|
[5] |
RAUN Yuan, WU Tian-feng, YUAN Fang, WEN Xiao-lin.
Relationship between uric acid and bone mineral density in elderly type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 567-570.
|
[6] |
MA Xiao-qin, XIN Hua-wen, LI Yuan-qi, HUANG Hui, ZHAO Li, YU Ai-rong, LI Wei-liang, WU Xiao-chun.
Association of HGPRT activity and gene polymorphism with adverse reactions caused by azathioprine in kidney transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 182-187.
|
[7] |
HUANG Qiong, ZHANG Liu-fu, CHENG Yan, SI Li, WEI Wei.
Effect of β3-adrenergic receptor gene Trp64Arg polymorphism on uric acid levels in a Chinese male type 2 diabetes mellitus population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 307-311.
|
[8] |
SUN Hong, WANG Shao-ming, ZHUANG Jie, HUANG Xu-hui, YAO Jin-zhou.
Inhibiting URAT1 gene expression and reducing blood uric acid level of Chinese Traditional Medicine such as smilax glabra
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 403-407.
|
[9] |
ZHU Li-li, ZHANG Li-jiu, FANG Hai-ming, YAO Ting-ting, YANG Jiao, WANG Jia-jia, XIA Quan.
Determination and pharmacokinetics of S-Adenosylmethionine in rats plasma by HPLC-UV
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(12): 1372-1377.
|
[10] |
ZHU Li-ran, CHEN Guang-liang.
Progress in uric acid transporters
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(11): 1289-1294.
|
[11] |
WU Yan.
Clinical investigation of ACE inhibitor combined with calcium antagonist on the patients with mild to moderate essential hypertension and it's effect on the serum uric acid level
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 317-321.
|
[12] |
ZHANG Wen-li, CHENG Hang, YANG Guo-ping.
Determination of the contents of febuxostat in human plasma by HPLC-FLU and studies on its pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(10): 1148-1152.
|
[13] |
WANG Hua-jie, ZHANG Guo-hua, ZHOU-Zhen, FAN Xiu-zhen.
Effects of SiMiaoSanJiaWeiFang on the expression of human UAT and URAT1 transporter genes in HK-2 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(9): 972-977.
|
[14] |
HAO Bin, LI Xin-yan, ZHOU Xiang-jun, WANG Yong-xiang.
Determination of plasma 5-(4-phenoxybutoxy) psoralen concentrations by HPLC-UV after dermal administration in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1234-1239.
|
[15] |
NI Li, CAO Xiao-mei, LI Jin-heng, CAI Ming-hong.
Relative bioavailability of three formulations of citalopra hydrobromide in Chinese healthy volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(9): 1068-1071.
|